KEVZARA Special Drug Use Investigation
Phase of Trial: Phase IV
Latest Information Update: 03 Apr 2019
Price : $35 *
At a glance
- Drugs Sarilumab (Primary)
- Indications Rheumatoid arthritis
- Focus Adverse reactions; Therapeutic Use
- Sponsors Sanofi K.K.
- 01 Jun 2018 Status changed from not yet recruiting to recruiting.
- 11 May 2018 New trial record